These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17218449

  • 1. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
    Anderson R, Steel HC, Cockeran R, Smith AM, von Gottberg A, de Gouveia L, Brink A, Klugman KP, Mitchell TJ, Feldman C.
    J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
    Anderson R, Steel HC, Cockeran R, von Gottberg A, de Gouveia L, Klugman KP, Mitchell TJ, Feldman C.
    J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG, DeCorby M, Noreddin A, Mendoza C, Cumming A, Nichol K, Wierzbowski A, Hoban DJ.
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [Abstract] [Full Text] [Related]

  • 4. Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae.
    Fukuda Y, Yanagihara K, Higashiyama Y, Miyazaki Y, Hirakata Y, Mukae H, Tomono K, Mizuta Y, Tsukamoto K, Kohno S.
    Eur Respir J; 2006 May; 27(5):1020-5. PubMed ID: 16455827
    [Abstract] [Full Text] [Related]

  • 5. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [Abstract] [Full Text] [Related]

  • 6. Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation.
    Domon H, Isono T, Hiyoshi T, Tamura H, Sasagawa K, Maekawa T, Hirayama S, Yanagihara K, Terao Y.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0031821. PubMed ID: 34468195
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of clarithromycin against Streptococcus pneumoniae expressing mef(A)-mediated resistance.
    Maglio D, Capitano B, Banevicius MA, Tessier PR, Nightingale CH, Nicolau DP.
    Int J Antimicrob Agents; 2004 May 31; 23(5):498-501. PubMed ID: 15120730
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
    Ma S, Jiao B, Ju Y, Zheng M, Ma R, Liu L, Zhang L, Shen X, Ma C, Meng Y, Wang H, Qi Y, Ma X, Cui W.
    Eur J Med Chem; 2011 Feb 31; 46(2):556-66. PubMed ID: 21159410
    [Abstract] [Full Text] [Related]

  • 9. Azithromycin iv pharmacodynamic parameters predicting Streptococcus pneumoniae killing in epithelial lining fluid versus serum: an in vitro pharmacodynamic simulation.
    Sevillano D, Alou L, Aguilar L, Echevarría O, Giménez MJ, Prieto J.
    J Antimicrob Chemother; 2006 Jun 31; 57(6):1128-33. PubMed ID: 16617063
    [Abstract] [Full Text] [Related]

  • 10. Clarithromycin mediated the expression of polymorphonuclear granulocyte response against streptococcus pneumoniae strains with different patterns of susceptibility and resistance to penicillin and clarithromycin.
    Cuffini AM, Tullio V, Mandras N, Roana J, Scalas D, Banche G, Carlone NA.
    Int J Tissue React; 2002 Jun 31; 24(1):37-44. PubMed ID: 12013153
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S, Taberner F, Domenech A, Cabellos C, Tubau F, Liñares J, Viladrich PF, Gudiol F.
    J Antimicrob Chemother; 2006 May 31; 57(5):931-6. PubMed ID: 16507562
    [Abstract] [Full Text] [Related]

  • 12. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
    Ikenaga M, Kosowska-Shick K, Gotoh K, Hidaka H, Koga H, Masunaga K, Nagai K, Tsumura N, Appelbaum PC, Matsuishi T.
    Diagn Microbiol Infect Dis; 2008 Sep 31; 62(1):16-22. PubMed ID: 18068325
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.
    Domon H, Maekawa T, Yonezawa D, Nagai K, Oda M, Yanagihara K, Terao Y.
    Antimicrob Agents Chemother; 2018 Nov 31; 62(11):. PubMed ID: 30181369
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations.
    Noreddin AM, Roberts D, Nichol K, Wierzbowski A, Hoban DJ, Zhanel GG.
    Antimicrob Agents Chemother; 2002 Dec 31; 46(12):4029-34. PubMed ID: 12435719
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.
    Sun HK, Lee SY, Banevicius MA, Du X, Maglio D, Nicolau DP.
    J Antimicrob Chemother; 2005 Sep 31; 56(3):559-65. PubMed ID: 16024590
    [Abstract] [Full Text] [Related]

  • 16. [Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae].
    Ploy MC, Mounier M, Denis F.
    Pathol Biol (Paris); 1994 May 31; 42(5):379-84. PubMed ID: 7824300
    [Abstract] [Full Text] [Related]

  • 17. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z, Ozbek OA, Bicmen M, Gur D.
    Jpn J Infect Dis; 2008 Nov 31; 61(6):490-3. PubMed ID: 19050364
    [Abstract] [Full Text] [Related]

  • 18. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
    Daikos GL, Koutsolioutsou A, Tsiodras S, Theodoridou M, Koutouzis EI, Charissiadou A, Pangalis A, Michos AG, Chaidopoulou F, Braoudaki M, Syriopoulou VP.
    Diagn Microbiol Infect Dis; 2008 Apr 31; 60(4):393-8. PubMed ID: 18077121
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.